Get a glimpse into our company and investor data—powered by the PitchBook Platform
M&ALATEST DEAL TYPE
$18MLATEST DEAL AMOUNT
Provider of medical kits and reagents. The company is engaged in the design, manufacture, validation and supply of polymerase chain reaction(PCR) kits which are used to generate copies of a particular DNA sequence.